e prospectively audited 79 patients undergoing primary knee or hip arthroplasty (38 knees, 41 hips) and found that 66% (58% of knees, 73% of hips) had at least one unit of blood transfused postoperatively, with a mean transfusion requirement of 1.3 units per patient (1.1 for knees, 0 to 6; 1.5 for hips, 0 to 4).
e prospectively audited 79 patients undergoing primary knee or hip arthroplasty (38 knees, 41 hips) and found that 66% (58% of knees, 73% of hips) had at least one unit of blood transfused postoperatively, with a mean transfusion requirement of 1.3 units per patient (1.1 for knees, 0 to 6; 1.5 for hips, 0 to 4).
We then established a new protocol for postoperative blood transfusion. This requires the calculation of the maximum allowable blood loss (MABL) that each individual patient can safely lose based upon their weight and preoperative haematocrit. The total blood loss up to this volume is replaced with colloid. When a patient's total blood loss reaches their MABL their haematocrit is measured at the bedside using the Microspin system (Bayer plc, Newbury, UK). If their haematocrit is low (<0.30 for men, <0.27 for women), blood is transfused. As a safety net all patients have their haemoglobin formally checked on days 1, 2, and 3 after surgery and have a transfusion if the haemoglobin levels are less than 8.5 g/dl.
We In England and Wales approximately 30 000 knee and 37 800 hip arthroplasties are performed every year.
1 Many departments do not have the facility to use autologous blood or reinfusion drains for the management of postoperative transfusion.
Allogenic blood is very expensive, 2 with potential disadvantages to the patient that could be avoided by eliminating unnecessary transfusion. 3, 4 Our objective was to audit prospectively the amount of blood which we were transfusing in elective joint surgery and to establish a new, more scientifically based postoperative protocol in order to see if we could change our practice and reduce transfusion requirements.
Patients and Methods
We prospectively audited 79 patients undergoing primary hip or knee arthroplasty between October 2000 and January 2001 (38 knees, 41 hips). The patients were all inpatients in our elective orthopaedic unit (Sharoe Green Hospital, Preston, UK) which undertakes only planned elective surgery. All patients had a full blood count measured approximately two weeks before surgery in the preoperative assessment clinic.
Originally, we did not have an established protocol for blood transfusion in the postoperative period. As a result, the amount of blood which a patient received in the immediate (less than 24 hours) postoperative period was dependent on both the anaesthetist's preferences and the doctor on call. The practice after 24 hours was to check the full blood count and if this was below 9.0 g/dl the patient received two units of allogenic blood.
Data recorded for this initial audit included: 1) clinical details including weight; 2) operation; 3) preoperative haematological indices; 4) preoperative blood loss; 5) postoperative drain losses; 6) postoperative haematological indices; and 7) number of units transfused.
After this initial audit we introduced a new protocol, based on previous work by McSwiney et al, 5 and prospectively audited a further 82 consecutive patients undergoing primary arthroplasty of the lower limb (35 knees, 47 hips). The same data were recorded for these patients.
The new protocol consisted of calculating the maximum allowable blood loss (MABL) for each patient. This was done using the formula: MABL in ml = Estimated blood volume (EBV) x (Hct (pre)-Hct (min)) / Hct (pre) where EBV = the patient's weight in kg x 70, Hct (pre) = preoperative haematocrit and Hct (min) = minimum allowable haematocrit (0.30 for men, 0.27 for women).
Maintenance of fluid loss both during the operation and after surgery was with crystalloid. The total blood loss (peroperatively, and postoperatively from the drains) up to the MABL was replaced with colloid. When the patient's total blood loss became equal to their MABL their haematocrit was measured on the ward by using a Microspin centrifuge (Bayer plc, Newbury, UK). This technique required the collection of a capillary tube filled with the patient's blood Transfusion protocol summarised as a flowchart.
using a finger prick performed at the bedside. If their haematocrit was greater than the minimum allowable for their gender, 6 their blood loss continued to be replaced with colloid. If the haematocrit was below the minimum allowable, one unit of blood was transfused. The haematocrit was then rechecked and again for every 500 ml of blood lost over the MABL. This cycle continued until the patient's haematocrit was greater than the minimum allowable and until the drains were removed 24 hours after surgery. The protocol was summarised in a flow chart (Fig. 1) and made available to medical and nursing staff on the wards.
As a safety measure, the full blood count was checked on a standard venous sample on days 1, 2 and 3 after surgery. If the haemoglobin was below 8.5 g/dl the patient was transfused one unit of blood and the haemoglobin rechecked. If the postoperative haemoglobin was between 8.5 and 10 g/dl the patient was prescribed oral ferrous sulphate 200 mg tds for two weeks. A condition was made that if any patient became symptomatic of anaemia, or unwell in any way, they would be reviewed by a medical officer. If transfusion was then deemed necessary it was administered regardless of the patient's haematological indices.
This postoperative transfusion protocol had the approval of the hospital Ethics Committee.
Results
The number of patients operated upon, their clinical details, haematological indices, total blood loss, number of units transfused, predischarge haemoglobin and length of stay before the introduction of the new protocol are shown in Table I . The same data for the patients who were audited after the introduction of the new protocol are shown in Table  II . The frequency of blood transfusion for knees and hips as a group (Fig. 2 ) and for knees (Fig. 3) and hips (Fig. 4) individually, before and after the introduction of the new protocol is shown.
The results were sent to a regional department of medical statistics for assessment. A log-linear model for Poisson counts was used in order to describe the expected number of units of blood transfused as a function of the protocol and the operation site together with the patients' age, gender, weight and preoperative haemoglobin. It was shown that the number of units of blood transfused was significantly less under the new protocol (p < 0.001) using a likelihood ratio test. The estimated reduction in the number of units of blood transfused was 59% if all other factors were the same. The patient's weight and preoperative haemoglobin were inversely related to the requirement for transfusion, with a higher value in both indicating fewer units of blood required. Age and gender did not influence the amount of blood lost. The distribution of the preoperative variables of age, gender, weight and haemoglobin were each shown to be similar for the two treatment groups. The mean predischarge haemoglobin was only 0.6 g/dl lower for the patients exposed to the new protocol despite the reduction in the number of units of blood transfused.
Discussion
Our department has only allogenic blood for transfusion after surgery. At the time of this study we did not have sufficient funding for reinfusion drains and we did not practise other means of saving allogenic blood such as autotransfusion, autologous predonation or normovolaemic haemodilution. These are processes which require considerable Transfusion requirements (a) for knees and hips before the new protocol (n = 79) and (b) for knees and hips using the new protocol (n = 82).
investment and expertise. It was therefore important to use as little allogenic blood as possible without detriment to the patient. After our initial audit we thought that we may be overtransfusing in many cases. We thus decided to initiate the new protocol which was based on previous work, 5 but with some modifications. The new protocol uses calculations which are based upon physiological principles in order to determine how much blood a patient can safely lose. The minimum haematocrit values and transfusion trigger of 8.5 g/dl were chosen, based upon previous clinical work 6, 7 and laboratory work undertaken with in vitro rheological studies of diluted blood. 8 The exact costs of transfusion are hard to quantify. The cost of one unit of blood in our department is approximately £85, but the cost from region to region can vary from £50 to £200 per unit. 2 There are also hidden costs such as increased patient stay (about £300 per day) and treatment for complications. It can be seen from these simple figures that if one unit of blood less per patient was transfused, and the length of stay was reduced by one day, a department which performs 400 arthroplasties of the lower limb each year can save approximately £150 000 per annum.
There is still a traditional view based on the original work of Adams and Lundy, 9 that patients should be transfused if the postoperative haemoglobin falls below 10 g/dl or the haematocrit to below 0.30. This value was based on the physiological knowledge at that time and may have been appropriate. However, our understanding of human physiology, oxygen delivery and the safety and risks of allogenic transfusion has changed considerably. The transfusion trigger of 10 g/dl is still widely followed. 10, 11 This trigger was questioned at the National Institute of Health Consensus Development Conference in 1988. 12 The recommendation of the conference was that a lower level of haemoglobin (8 g/dl) should act as the trigger for transfusion. It was also suggested that decisions about transfusion should be based on an assessment of clinical needs and symptoms rather than laboratory values alone. As a result of studies of the haematological indices in Jehovah's witnesses who have undergone major surgery, we have considerable information regarding the low levels of haemoglobin which can be tolerated. [13] [14] [15] From our own experience it appears that some medical and nursing staff consider that our transfusion trigger of 8.5 g/dl is too low. However, the British Transfusion Task Force recommends that elderly patients can be allowed a haemoglobin as low as 8.0 g/dl, and younger patients as low as 7.0 g/dl 16 before transfusion is required.
The serious hazards of transfusion (SHOT) reporting system continues to report deaths and serious morbidity due to the transfusion of allogenic blood. 17 Bierbaum et al 18 reviewed 10 000 patients who had had total joint arthroplasty and found a rate of infection (deep infection, wound infection, chest infection, urinary tract infection, and others) of 7% in transfused patients compared with 3% for those who did not require a blood transfusion. It was also noted that each transfused patient stayed in hospital for one additional day. It is clearly preferable not to transfuse blood if possible, especially in orthopaedic surgery in which deep infection is a devastating complication.
We suggest that there should be an established protocol for transfusion in an elective orthopaedic unit. We have care pathways for our arthroplasties and we hope that our new protocol will become part of that pathway so that all patients will receive the correct amount of blood.
While our results may look impressive, we were probably overtransfusing our patients before we instituted our new protocol. If our transfusion frequency is compared with that of other authors, [18] [19] [20] [21] it can be seen that this protocol could be of value if instituted elsewhere. We are aware that not all surgeons use drains for their arthroplasties of the lower limbs. This does not, however, make a protocol such as ours obsolete. A bedside haematocrit estimation may still be used at standard intervals in the postoperative period. This would allow medical staff to monitor the patient's needs for transfusion more closely. It would also avoid the inevitable delay which is experienced when a formal haemoglobin is checked on postoperative day 1, the result of which is often unavailable until day 2. Many units now have reinfusion drains. Clearly their use, combined with a protocol such as ours, could save even more allogenic blood. Several other papers [19] [20] [21] [22] have established a link between the preoperative levels of haemoglobin and the need for postoperative transfusion, in an attempt to predict which patients are likely to require a transfusion. Our statistical analysis confirms that the preoperative level of haemoglobin and weight are inversely related to the quantity of blood transfusion required.
Our results demonstrate how guidelines can influence transfusion practice and improve the quality of patient care. They also show that by applying physiological principles to postoperative transfusion and lowering the transfusion trigger in elective orthopaedic surgery, the amount of allogenic blood transfused can be reduced without detriment to the patient. We believe that our protocol for postoperative blood transfusion carefully balances the need for transfusion with its inherent risks to the patient and cost to a hospital.
